Live Breaking News & Updates on Serum institute of life sciences

Stay informed with the latest breaking news from Serum institute of life sciences on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Serum institute of life sciences and stay connected to the pulse of your community

Natasha Poonawalla's Diwali a starry-sequinned-shimmery one, starring Rishi Sunak and Priyanka Chopra!

The Chairperson of Serum Life Sciences UK thanked Sunak for the growing support and encouragement.

India , United-kingdom , Sunak , Gujarat , British , Adar-poonawalla , Natasha-poonawalla-instagram , Priyanka-chopra-jonas , Instagram , Serum-institute-of-india , London-school-of-economics , Villoo-poonawalla-foundation

India's Serum Institute to double investment in Biocon Biologics

Serum Institute of India, which is the world’s biggest vaccine maker, is set to ramp up its investment in one of Biocon’s subsidiaries to $300 million.

India , Abu-dhabi , Abuz-aby , United-arab-emirates , Kiran-mazumdar-shaw , Biocon-pharma , Biocon-biologics , Abu-dhabi-developmental-holding-company , Serum-institute-of-life-sciences , Biocon , India-value-fund-advisors , Goldman-sachs

India's Serum to double investment in Biocon's unit to $300 million

The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd's units, giving it access to 100 million doses of vaccines annually along with the distribution rights to... | April 25, 2023

India , Bengaluru , Karnataka , Rama-venkat , Nivedita-bhattacharjee , Biocon-biologics , Biocon , Serum-institute-of-life-sciences , Biocon-pharma-ltd , Serum-institute-of-india , Biocon-biologics-ltd , Serum-institute

Serum & Biocon Biologics agree to Restructure Equity Investment

Biocon Biologics Ltd and Serum Institute of Life Sciences have reached an agreement to withdraw from the original equity structure contemplated under their Strategic Alliance announced in Sep, 2021.

Karnataka , India , Biocon-biologics , Strategic-alliance , Biocon , Biocon-biologics-limited , Biocon-pharma , Wholly-owned-subsidiary-of-biocon , Serum-life-sciences , Serum-institute-of-life-sciences , National-company-law-tribunal , Restructure-equity

Serum Institute of Life Sciences to double investment in Biocon's unit to $300 million

Biocon had signed an agreement in September 2021 to offer about 15% stake in Biocon Biologics to Serum Institute of Life Sciences.

Biocon-biologics , Serum-institute-of-life-sciences , Biocon , Serum-institute , Life-sciences , Erum-institute-biocon , Erum-institute-biocon-deal , Ii-biocon-deal , Ii-biocon-investment ,

SILS To Invest 150 Mn More Into Biocon Biologics

SILS To Invest 150 Mn More Into Biocon Biologics
businessworld.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessworld.in Daily Mail and Mail on Sunday newspapers.

Karnataka , India , Biocon-biologics , Biocon-pharma , Serum-institute-of-life-sciences , Biocon-biologics-limited , Serum-life-sciences , Biocon , Strategic-alliance , National-company-law-tribunal , Serum-institute , Life-sciences

Serum Institute To Double Investment In Biocon's Unit To $300 Million

The Serum Institute of Life Sciences will double its investment in one of Biocon Ltd's units, giving it access to 100 million doses of vaccines annually along with the distribution rights to Serum's vaccine portfolio, the Indian biopharma firm said today.

India , Biocon-biologics , Biocon-biologics-ltd , Serum-institute-of-life-sciences , Biocon-pharma-ltd , Biocon-ltd , Million-serum-institute-of-life-sciences , Biocon , Serum-institute-of-india , Serum-institute , Life-sciences , Business

Biocon-Serum deal: Serum to double investment in Biocon's unit to $300 million

Serum Life Sciences would make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma Limited.

Biocon-biologics , Kiran-mazumdar-shaw , India-biocon-ltd , Serum-institute-of-life-sciences , Biocon-limited-kiran-mazumdar-shaw , Biocon-pharma , Serum-institute , Serum-institute-of-life-science , Biocon , Serum-life-sciences , Biocon-ltd-chairman , Managing-director-kiran-mazumdar-shaw

Serum Institute to invest $300 mn in Biocon's unit, provide access to 100 mn vaccine doses annually

Serum Institute of Life Sciences has announced to double up its investment in Biocon's unit to $300 million. With this, Biocon's unit will also get access to SILS' 100 million vaccine doses annually

India , Karnataka , Biocon-biologics , Serum-institute-of-india , Strategic-alliance , National-company-law-tribunal , Biocon , Serum-institute-of-life-sciences , Serum-life-sciences , Biocon-ltd , Biocon-biologics-ltd , Biocon-pharma

Serum Life Sciences to make additional $150 million funding in Biocon Biologics

This investment is in addition to the $ 150 million that SILS had invested in Biocon Biologics in November 2022, resulting in SILS’s aggregate equity investment in BBL amounting to $300 million.

Karnataka , India , Biocon-biologics , Biocon-biologics-limited , Strategic-alliance , Biocon-pharma , Wholly-owned-subsidiary-of-biocon , Serum-institute-of-life-sciences , Serum-life-sciences , National-company-law-tribunal , Biocon , Serum-institute